My WebLink
|
Help
|
About
|
Sign Out
05
City of Pleasanton
>
CITY CLERK
>
AGENDA PACKETS
>
2021
>
072021
>
05
Metadata
Thumbnails
Annotations
Entry Properties
Last modified
7/15/2021 11:56:33 AM
Creation date
7/15/2021 11:50:40 AM
Metadata
Fields
Template:
CITY CLERK
CITY CLERK - TYPE
AGENDA REPORT
DOCUMENT DATE
7/20/2021
DESTRUCT DATE
15Y
There are no annotations on this page.
Document management portal powered by Laserfiche WebLink 9 © 1998-2015
Laserfiche.
All rights reserved.
/
45
PDF
Print
Pages to print
Enter page numbers and/or page ranges separated by commas. For example, 1,3,5-12.
After downloading, print the document using a PDF reader (e.g. Adobe Reader).
View images
View plain text
ORDINANCE NO.2218 <br />AN ORDINANCE OF THE CITY COUNCIL OF THE CITY OF PLEASANTON <br />APPROVING A DEVELOPMENT AGREEMENT BETWEEN THE CITY OF <br />PLEASANTON AND 1OX GENOMICS, INC. <br />WHEREAS, Government Code 5565865-65869.5 authorizes a city to enter into binding <br />development agreements with persons having legal interests in real property for the development <br />of such property, and <br />WHEREAS, 10x Genomics, lnc. has applied to the City for a Development Agreement <br />concerning its PUD rezoning and development plan applications for a Planned Unit Development <br />(PUD) Rezoning to rezone the subject parcel from C-R (p) (Regional Commercial - peripheral <br />sites) District to PUD-C-O (Planned Unit Development - Commercial-Office) District and a PUD <br />Development Plan to construct up to three new multi-story research and development, office and <br />laboratory buildings totaling approximately 381,000 square feet, a parking structure, and related <br />site improvements over multiple phases at its 1701 Springdale Avenue property, referred to as <br />PUD-139 and P20-0973 (collectively the "Project"); and <br />WHEREAS, after public notice, on May 25,2021, the Planning Commission held a hearing <br />and recommended that the City Council make a finding of General Plan conformity for the <br />Development Agreement; and <br />WHEREAS, at its meeting of June 15,2021, the City Council reviewed the agenda report <br />from the Director of Community Development together with a copy of the agenda report to the <br />Planning Commission on this matter, and held duly-noticed public hearing, at which time 10x <br />Genomics, lnc. and members of the public were offered an opportunity to present evidence <br />regarding the development agreement; and <br />WHEREAS, the development agreement is for the Project for which the City Council <br />adopted a Mitigated Negative Declaration on June 15,2021. <br />NOW, THEREFORE, THE CITY COUNCIL OF THE CITY OF PLEASANTON DOES <br />HEREBY ORDAIN AS FOLLOWS: <br />SECTION 1. Finds that the proposed development agreement is consistent with the <br />City's General Plan. <br />SECTION 2. Approves the Development Agreement between the City of Pleasanton and <br />10x Genomics, lnc., a copy of which is attached hereto as ExhibitA and incorporated herein by <br />this reference, and authorizes the City Manager to sign the Development Agreement in generally <br />the form shown in Exhibit A, subject to minor modifications approved by the City Manager and <br />City Attorney. <br />SEGTION 3. A summary of this ordinance shall be published once within fifteen (15) <br />days after its adoption in "The Valley Times," a newspaper of general circulation published in the <br />City of Pleasanton, and the complete ordinance shall be posted forfifteen (15) days in the City <br />Clerk's office within fifteen (15) days after its adoption.
The URL can be used to link to this page
Your browser does not support the video tag.